Zur Rose Group AG Stock
Price
Target price
€6.41
€6.41
2.080%
0.13
2.080%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Financial data and news for Zur Rose Group
sharewise wants to provide you with the best news and tools for Zur Rose Group, so we directly link to the best financial data sources.
Financials
News
DocMorris announces the results of the tender offer for its Outstanding Convertible Bonds due 2026
DocMorris announces the results of the tender offer for its Outstanding Convertible Bonds due 2026
DocMorris announces the start of the tender offer period for its Outstanding Convertible Bonds due 2026
DocMorris announces the start of the tender offer period for its Outstanding Convertible Bonds due 2026
DocMorris successfully completes the placement of CHF 49.6 million Convertible Bonds due 2028
DocMorris successfully completes the placement of CHF 49.6 million Convertible Bonds due 2028
DocMorris launches approx. CHF 45 million Convertible Bonds due 2028 to fund early buyback of Convertible Bonds 2026
DocMorris launches approx. CHF 45 million Convertible Bonds due 2028 to fund early buyback of Convertible Bonds 2026
DocMorris accelerates sequential Rx growth and increases non-Rx revenue
DocMorris accelerates sequential Rx growth and increases non-Rx revenue
DocMorris increases Rx revenue by over 40 per cent in the first half of the year and continues to expand its health ecosystem
DocMorris increases Rx revenue by over 40 per cent in the first half of the year and continues to expand its health ecosystem
DocMorris AG: Federal Court of Justice confirms admissibility of prescription bonuses
DocMorris AG: Federal Court of Justice confirms admissibility of prescription bonuses
gematik extends DocMorris CardLink approval until January 2027
gematik extends DocMorris CardLink approval until January 2027